Synmosa Biopharma Corporation (4114) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Synmosa Biopharma Corporation (4114) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Synmosa Biopharma Corporation (4114) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Synmosa Biopharma Corporation (4114) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
28 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Synmosa Biopharma Corporation (Synmosa) is a fully integrated specialty pharmaceutical company that manufactures, markets and distributes ethical, over-the-counter and healthcare products. The company also produces non-pharmaceutical products such as cosmeceutical and nutrition products, and food supplements in effervescent tablet and granule forms. It manufactures medicines covering areas of cardiovascular, respiratory, urology, gynecology and cancer treatment. The company manufactures its products in various dosage forms including nasal sprays, solids, semi-solids and liquids.

Synmosa Biopharma Corporation (4114) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of e

  
Source:
Document ID
GDPH195109D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Synmosa Biopharma Corporation, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Synmosa Biopharma Corporation, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Synmosa Biopharma Corporation, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Synmosa Biopharma Corporation, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Synmosa Biopharma Corporation, Medical Devices Deals, 2010 to YTD 201691
Synmosa Biopharma Corporation, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Synmosa Biopharma Corporation, Pharmaceuticals &Healthcare, Deal Details1114
  Venture Financing111
    Innopharmax Raises Funds in Venture Financing111
  Licensing Agreements121
    Synmosa Biopharma Enters into Licensing Agreement with Kyorin Pharma121
    InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution131
    DCB Enters Into Licensing Agreement With Synmosa Biopharma141
  Equity Offering151
    Synmosa Biopharma Raises USD2 Million in Public Offering of Shares152
    Synmosa Biopharma Raises USD15 Million in Rights Offering of Shares172
    Innopharmax Raises USD8 Million in Rights Offering of Shares192
    Innopharmax Completes IPO211
  Acquisition221
    Innopharmax to Acquire 16% Stake in Pharma Company221
    Synmosa Biopharma Acquires Ningbo Youhe Commercial Pharma231
    Synmosa Biopharma To Acquire Majority Stake In Pharma Company241
Synmosa Biopharma Corporation - Key Competitors251
Key Employees261
Locations And Subsidiaries271
  Head Office271
  Other Locations &Subsidiaries271
Appendix281
  Methodology281
  About GlobalData281
  Contact Us281
  Disclaimer281

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Synmosa Biopharma Corporation (4114) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Synmosa-Biopharma-Corporation-4114-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7759>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Synmosa Biopharma Corporation (4114) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Synmosa-Biopharma-Corporation-4114-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7759>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research